Clinical Trials Directory

Trials / Completed

CompletedNCT03428113

Measuring Bladder Volumes Scanning in the ICU

Measuring Bladder Volumes With Ultrasound and Bladder Scanning in the ICU

Status
Completed
Phase
Study type
Observational
Enrollment
75 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

ICU patients are at risk for catheter associated urinary tract infection. Frequently patients can't tell clinicians if they need to void if the catheter is removed. If clinicians know that an accurate volume measurement s of urine volume in the bladder can be obtained when the catheter is removed, catheters could be removed earlier and more frequently and thus possibly avoid an infection. For this study, measures with ultrasound (directly visualizing the bladder to measure), bladder scanner (partially blind measure with placement of scanner over the expected bladder location on the skin) and urine catheterized volume will be obtained. The investigators also want to know if the technology is user dependent. The study will include 2 levels of nurses RN and advanced practice RN (APRN) perform the bladder scanner. An APRN and MD will conduct the ultrasound. Ultrasound is technology primarily used by physicians but APRNs are using the technology technology more frequently. After these 4 measurements, the patient's nurse will perform an intermittent straight catheterization (catheter inserted, urine drained, and catheter removed) as the gold standard comparison.

Detailed description

The purpose of this correlational descriptive study is to compare measured bladder volumes with a bladder scanner (Verathon Prime), 3D ultrasound (Sono-Site II) and straight catheterization in ICU patients with low urine output receiving dialysis and in ICU patients unable to void. Upon consent of patient or LAR, patient's age, gender and BMI with the assigned study code number will be recorded on enrollment log. Study code number, patient initials and unit will be written on bedside data collection sheet. Sequence of 4 non-invasive (1-4) measurement will vary from day to day (see below) 1. MD performs bladder ultrasound and records volume on data collection sheet and places in envelope 2. APRN performs bladder scanner and records volume on data collection sheet and places in envelope. 3. APRN performs bladder ultrasound and records volume on data collection sheet and places in envelope 4. Bedside RN performs bladder scanner and records volume on data collection sheet and places in envelope 5. The study team will record the data from the straight catheterization that is performed as part of clinical care. 6. APRN or research nurse will retrieve catheterization urine volume measurement from RN or from chart and record on data collection sheet Each enrolled patient will have these 4 measurements performed only on one day. Each clinician research team member will record their result on a data collection form with the study number, patient initials, day of week, clinician initials, observation of abdominal fluid, and comment section for any other observations. The clinician research team member will place the completed form for their measurement in an envelope with the study number on the outside while the next clinician is in the room obtaining the next measure. Data collection is complete after catheter volume is recorded.

Conditions

Interventions

TypeNameDescription
OTHERBladder Volume Measurement bladder scanner RNMeasure Urine Volume with Bladder Scanner by RN
OTHERBladder Volume Measurement Ultrasound APRNMeasure Urine Volume with Point of Care Ultrasound by APRN
OTHERBladder Volume Measurement bladder scanner APRNMeasure Urine Volume with Bladder Scanner by APRN
OTHERBladder Volume Measurement Ultrasound MDMeasure Urine Volume with Point of Care Ultrasound by MD
OTHERIntermittent Straight CatheterizationMeasure Urine Volume with Intermittent Straight Catheterization

Timeline

Start date
2017-12-04
Primary completion
2018-07-31
Completion
2018-11-01
First posted
2018-02-09
Last updated
2019-04-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03428113. Inclusion in this directory is not an endorsement.